Masculinizing genitoplasty in male pseudohermaphroditism

Pediatric Endocrinology Reviews

Volumn 2, Issue 1, 2004, Pages 15-20

  Farkas, A ^a   Koulikov, D ^b   Chertin, B ^b  

^a SHAARE ZEDEK MEDICAL CENTER   (Israel)

^b NONE

Author keywords

Ambiguous genitalia; Hypospadias repair; Masculinizing genitoplasty; Scrotal transposition

Indexed keywords

ANDROSTANOLONE; ANDROSTENEDIONE; MUELLERIAN INHIBITING FACTOR; STEROID 5ALPHA REDUCTASE; TESTOSTERONE; TESTOSTERONE 17BETA DEHYDROGENASE;

CONGENITAL ADRENAL HYPERPLASIA; CRYPTORCHISM; ESTHETIC SURGERY; HUMAN; HYPOSPADIAS; MALE PSEUDOHERMAPHRODITISM; MASCULINIZING GENITOPLASTY; PLASTIC SURGERY; PREOPERATIVE EVALUATION; REVIEW; SCROTUM DISORDER; SEX DIFFERENTIATION; SRY GENE; SURGICAL TECHNIQUE; TRANSURETHRAL RESECTION; URETHROPLASTY; VIRILIZATION;

17-HYDROXYSTEROID DEHYDROGENASES; CHILD; FEMALE; GENITALIA, MALE; HUMANS; MALE; PENIS; PSEUDOHERMAPHRODITISM; SURGERY, PLASTIC; SURGICAL FLAPS; UROGENITAL SURGICAL PROCEDURES;

EID: 12444289600     PISSN: 15654753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (28)

1. Forrest MC. Ambiguous genitalia/ intersex: endocrine aspects. In: Gearhart JP, Rink RC, Mouriquand PDE, eds. Pediatric urology. Philadelphia: WB Saunders company, 2001;623-658
2. Migeon CI, Wisneiwski AB, Gearhart JP, Meyer-Bahlburg HFL, Rock JA, Brown TR, Casella SJ, Maret A, Ngai KM, Money J, Berkovitz GD. Ambiguous genitalia with perineoscrotal hypospadias in 46 XY individuals: long-term medical surgical and psychosexual outcome. Pediatrics 2002;110(3):E31
3. Morel Y, Rey R, Teinturier C, Nicolino M, Michel-Calemard L, Mowszowicz I, Jaubert F, Fellous M, Chaussain JL, Chatelain P, David M, Nihoul-Fekete, Forest MC, Josso H. Aetiological diagnosis of male sex ambiguity: a collaborative study. Eur J Pediatr 2002;161:49-59
4. American academy of pediatrics. Committee on Genetics, section on endocrinology, section on urology. Evaluation of the newborn with developmental anomalies of the external genitalia. Pediatrics 2000;16(1):138-142
5. Wisneiwski AB, Migeon CI. Gender identity/role differentiation in adolescents affected by syndromes of abnormal sex differentiation. Adolescent medicine: state of the art reviewers. 2002;13(1):119-128
6. Migeon CI, Wisneiwski AB, Brown TB, Rock JA, Meyer-Bahlburg FL, Money J, Berkovitz GD. 46XY intersex individuals: phenotypic and etiologic classification, knowledge of condition, and satisfaction with knowledge in adulthood. Pediatrics 2002;110(3):E32
7. Diamond M, Sigmungston HK. Management of intersexuality. Arch Pediatr Adolesc Med 1997;151:1046-1050
8. Meyer-Bahlburg HFL. Gender assessment and reassignment in 46XY pseudohermaphroditism and related conditions. The J of Clinical Endocrinology and Metabolism 1999;84(10):3455-3458
9. Wilson BE, Reiner WG. Management of intersex: a shifting paradigm. The J of Clinical Ethics 1998;9(4):360-369
10. Sultan C, Paris F, Jeandel C, Lumbroso S, Galifer RB. Ambiguous genitalia in the newborn. Semin Reprod Med 2002;20:181-188
11. Imperaro-Mc.Ginley J, Guerrero L, Peterson RE. Steroid 5α reductase deficiency in man. An inherited form of male pseudohermaphroditism. Science 1974;186:1213-1215
12. Farkas A, Rosler A. Ten years experience with masculinizing genitoplasty in male pseudohermaphroditism due to 17?-hydroxysteroid dehydrogenase deficiency. Eur J Pediatr 1993;152(Suppl 2):S88-S90
13. Gross DJ, Landau H, Kohn G, Farkas A, Elrayyes E, El-Shawwa R, Lasch EE, Rosler A. Male pseudohermaphroditism due to17?-hydroxysteroid dehydrogenase deficiency: gender reassignment in early infancy. Act Endocrinolodica. 1986;112:238-246
14. Mendonca BB, Inacio M, Arnold UP, Costa EMF, Bloise W, Martin RM, Denes FT, Silva FAQ, Andersson S, Lindqvist A, Wilson JD. Male pseudohermaphroditism due to to17?-hydroxysteroid dehydrogenase 3 deficiency. Medicine 2000;79(5):299-309
15. Hochberg Z, Chayen R, Reiss N, Falik Z, Makler A, Munichor M, Farkas A, Goldfarb H, Ohana O, Hiort O. Clinical, biochemical and genetic findings in a large pedigree of male and female patients with 5?-reducatase deficiency. J of Clinical Endocrinology and Metabolism. 1996;81(8):2821-2827
16. Van Niekerk WA. True hermaphroditism: an analytic review with a report of 3 new cases. Am J Obstet Gynecol 1976;126(7):890-907
17. Morgan RJ, Williams DI, Pryor JP. Mullerian duct remnants in the male. Br J Urol 1979;488-492
18. Desautel MG, Stock J, Hanna MK. Mullerian duct remnants: surgical management and fertility issues. J Urol 1999;162:1008-1013
19. Farkas A, Chertin B, Hadas-Halpren I. 1-stage feminizing genitoplasty: 8 years of experience with 49 cases. J Urol 2001;165:2341-2346
20. Farkas A, Chertin B. Feminizing genitoplasty. State of the art. J Ped Endoc and Metab 2001;14:713-722
21. Kipnis K, Diamond M. Pediatric ethics and surgical assignment of sex. The Journal of Clinical Ethics 1998;9(4):398-410
22. Eckstein B, Cohen S, Farkas A, Roster A. The nature of the defect in familial male pseudohermaphroditism in Arabs of Gaza. Journal of Clinical Endocrinology and Metabolism 1989;68(2):477-485
23. Reiner WG. Psychological and psychiatrist aspects of genitourinary conditions. In: Gearhart JP, Rink RC, Mouriquand PDE, eds. Pediatric urology. Philadelphia: WB Saunders company, 2001;696-704
24. Donahoe PK, Crawford JD, Hendren WH. Management of neonates and children with male pseudohermaphroditism. J of Ped Surg 1977;12(6):1045-1056
25. Duckett JW, Baskin LS. Genitoplasty for intersex anomalies. Eur J Pediatr 1993;152(Suppl 2):S80-S84
26. Chertin B, Koulikov D, Fridmans A, Farkas A. Dorsal tunica albuginea plication for correction of congenital and acquired penile curvatures: long-term follow-up. BJU 2004;93:379-381
27. Baskin LS, Erol A, Li YW, Liu WH. Anatomy of the neurovascular bundle: is safe mobilization possible? J Urol 2000;164:977-980
28. Yarbmough WJ, Johnston JH. Crawford modification of Denis Browne hypospadias procedure. J Urol 1977;117:782-783